SynBioLab
PrivateLast Round
Series A
Feb 13, 2023
Total Funding Raised
$1.55M
Company Overview
SynBioLab operates in Healthcare & Life Sciences and is based in Jiaxing. Its latest recorded funding round was a Series A round in February 2023.
SynBioLab is a biotechnology company that develops microbial cell factories to produce high-value-added plant-derived medicinal compounds and chemical raw materials.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Smart Manufacturing, Sustainable Materials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SynBioLab Comparables
Compare SynBioLab with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cataya Bio | 87% | |
| Bota Biosciences | 83% | |
| Hangzhou Viablife Biotech Co., Ltd. | 81% |
For institutional investors. Book with your work email.
SynBioLab Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Feb 13, 2023 | ||||
| Early Funding | Sep 30, 2021 |
For institutional investors. Book with your work email.
SynBioLab Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Green Leaf Ventures | Series A |
| Bangming Capital | Series A |
| Kaitai Capital | Early Funding |
| 松禾资本 (Green Pine Capital Partners) | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 13, 2023
Raised Series A with Green Leaf Ventures and Bangming Capital.
- Sep 30, 2021
$1.55M raised, led by Kaitai Capital.
For institutional investors. Book with your work email.
SynBioLab Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about SynBioLab's valuation, stock price, and market status.
Is SynBioLab a public or private company?
SynBioLab is a private company.
What is the current stock price of SynBioLab?
SynBioLab is a private company, so its shares have no public market price. Caplight tracks SynBioLab's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is SynBioLab worth (valuation)?
Valuation information for SynBioLab is not publicly available.
Can I buy SynBioLab stock?
SynBioLab shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was SynBioLab's last funding round?
SynBioLab's most recent funding round was Series A on February 13, 2023.
Who are the main investors in SynBioLab?
Key investors in SynBioLab include Kaitai Capital.
Will SynBioLab IPO soon?
No public IPO plans have been announced for SynBioLab.
How can I track SynBioLab secondary market activity?
Caplight tracks bids, offers, and trades in SynBioLab's shares on secondary markets.